Vitruvias Therapeutics thyroid tablet recalled in US
The US Food and Drug Administration recalled a lot of Vitruvias Therapeutics thyroid tablets due to potential superpotency, which could lead to serious health risks. This Class I recall affects tablets distributed nationwide between January 31 and September 30, 2025. Patients are advised to check their packaging for details and consult healthcare providers regarding potential symptoms.